Haviland Kate
SEC insider (Form 3/4/5 filer). CIK 0001663022. Director at Fulcrum Therapeutics, Inc. (FULC) and 3 other issuers. 19 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in CAMBRIDGE, MA.
Companies Haviland Kate has filed insider reports for
- Fulcrum Therapeutics, Inc. (FULC): Director
- Bicara Therapeutics Inc. (BCAX): Director
- Avalyn Pharma Inc. (AVLN): Director
- Blueprint Medicines Corp (BPMC): Officer, CHIEF EXECUTIVE OFFICER
Haviland Kate
CIK: 0001663022
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Jun 30, 2026FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
32K shares- - Jun 9, 2026BCAX
Bicara Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
19.5K shares- - Apr 29, 2026AVLN
Avalyn Pharma Inc.
AwardDirectStock Option (Right to Buy)
27K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
AwardDirect129.2K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
DispositionDirect224.4K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
Tender OfferDirect70.7K shares- - Jun 26, 2025FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
36K shares- - Jun 9, 2025BCAX
Bicara Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
23.7K shares- - Apr 1, 2025BPMC
Blueprint Medicines Corp
SaleDirect1.2K shares at avg. $87.34$105K - Apr 1, 2025BPMC
Blueprint Medicines Corp
SaleDirect600 shares at avg. $85.47$51K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 |  FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 32,000 | - | - | Direct |
| Jun 9, 2026 |  BCAX Bicara Therapeutics Inc. | Award Stock Option (Right to Buy) | 19,475 | - | - | Direct |
| Apr 29, 2026 |  AVLN Avalyn Pharma Inc. | Award Stock Option (Right to Buy) | 26,978 | - | - | Direct |
| Jul 17, 2025 |  BPMC Blueprint Medicines Corp | Award | 129,210 | - | - | Direct |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | Disposition | 224,410 | - | - | Direct |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | Tender Offer | 70,729 | - | - | Direct |
| Jun 26, 2025 | FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 36,000 | - | - | Direct |
| Jun 9, 2025 | BCAX Bicara Therapeutics Inc. | Award Stock Option (Right to Buy) | 23,746 | - | - | Direct |
| Apr 1, 2025 | BPMC Blueprint Medicines Corp | Sale | 1,200 | $87.34 | $104,808 | Direct |
| Apr 1, 2025 | BPMC Blueprint Medicines Corp | Sale | 600 | $85.47 | $51,282 | Direct |
1-10 of 19 transactions